These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30132064)

  • 21. Dimebon in Alzheimer's disease: old drug for new indication.
    Burns A; Jacoby R
    Lancet; 2008 Jul; 372(9634):179-80. PubMed ID: 18640436
    [No Abstract]   [Full Text] [Related]  

  • 22. Double-blind trial of imipramine in Alzheimer's disease patients with and without depression.
    Reifler BV; Teri L; Raskind M; Veith R; Barnes R; White E; McLean P
    Am J Psychiatry; 1989 Jan; 146(1):45-9. PubMed ID: 2643356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-tau vaccine in Alzheimer's disease: a tentative step.
    Panza F; Logroscino G
    Lancet Neurol; 2017 Feb; 16(2):99-100. PubMed ID: 27955996
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral physostigmine in Alzheimer's disease.
    Davis KL; Mohs RC; Davis BM; Horvath TB; Greenwald BS; Rosen WG; Levy MI; Johns CA
    Psychopharmacol Bull; 1983; 19(3):451-3. PubMed ID: 6635123
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment trial of oxiracetam in Alzheimer's disease.
    Green RC; Goldstein FC; Auchus AP; Presley R; Clark WS; Van Tuyl L; Green J; Hersch SM; Karp HR
    Arch Neurol; 1992 Nov; 49(11):1135-6. PubMed ID: 1444879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immunoglobulin for Alzheimer's disease.
    Relkin N
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):27-9. PubMed ID: 25546751
    [No Abstract]   [Full Text] [Related]  

  • 27. Intracerebroventricular bethanechol chloride infusion in Alzheimer's disease. Results of a collaborative double-blind study.
    Harbaugh RE; Reeder TM; Senter HJ; Knopman DS; Baskin DS; Pirozzolo F; Chui HC; Shetter AG; Bakay RA; Leblanc R
    J Neurosurg; 1989 Oct; 71(4):481-6. PubMed ID: 2571689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study.
    Mazza M; Capuano A; Bria P; Mazza S
    Eur J Neurol; 2006 Sep; 13(9):981-5. PubMed ID: 16930364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylphenidate for Apathy in Community-Dwelling Older Veterans With Mild Alzheimer's Disease: A Double-Blind, Randomized, Placebo-Controlled Trial.
    Padala PR; Padala KP; Lensing SY; Ramirez D; Monga V; Bopp MM; Roberson PK; Dennis RA; Petty F; Sullivan DH; Burke WJ
    Am J Psychiatry; 2018 Feb; 175(2):159-168. PubMed ID: 28945120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lecithin in the treatment of Alzheimer's disease.
    Weintraub S; Mesulam MM; Auty R; Baratz R; Cholakos BN; Kapust L; Ransil B; Tellers JG; Albert MS; LoCastro S; Moss M
    Arch Neurol; 1983 Aug; 40(8):527-8. PubMed ID: 6347143
    [No Abstract]   [Full Text] [Related]  

  • 31. Nimodipine for primary degenerative, mixed and vascular dementia.
    López-Arrieta JM; Birks J
    Cochrane Database Syst Rev; 2002; (3):CD000147. PubMed ID: 12137606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. THA, a putative drug in the treatment of Alzheimer's disease?
    Thal LJ
    Acta Neurol Scand Suppl; 1990; 129():27-8. PubMed ID: 2220321
    [No Abstract]   [Full Text] [Related]  

  • 33. Essential fatty acids in Alzheimer's disease.
    Corrigan FM; Van Rhijn A; Horrobin DF
    Ann N Y Acad Sci; 1991; 640():250-2. PubMed ID: 1776746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noradrenergic intervention in Alzheimer's disease.
    Crook T; Wilner E; Rothwell A; Winterling D; McEntee W
    Psychopharmacol Bull; 1992; 28(1):67-70. PubMed ID: 1609045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyrotropin-releasing hormone (TRH) and Alzheimer's disease.
    Peabody CA; Deblois TE; Tinklenberg JR
    Am J Psychiatry; 1986 Feb; 143(2):262-3. PubMed ID: 3080909
    [No Abstract]   [Full Text] [Related]  

  • 36. Alzheimer's disease and caregiver time.
    Moore MJ; Clipp EC
    Lancet; 1994 Jan; 343(8891):239-40. PubMed ID: 7904698
    [No Abstract]   [Full Text] [Related]  

  • 37. Addressing Possible Effects of Sleep Apnea in a Study of Methylphenidate for Apathy in Alzheimer's Disease: Response to Kolla and Mansukhani.
    Padala PR; Dennis RA; Padala KP
    Am J Psychiatry; 2018 Aug; 175(8):792-793. PubMed ID: 30064247
    [No Abstract]   [Full Text] [Related]  

  • 38. DHEA treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled trial.
    Leblhuber F; Haller H; Steiner K; Fuchs D
    Neurology; 2004 Mar; 62(6):1030. PubMed ID: 15037728
    [No Abstract]   [Full Text] [Related]  

  • 39. A double-blind crossover pilot study of l-deprenyl (selegiline) combined with cholinesterase inhibitor in Alzheimer's disease.
    Schneider LS; Olin JT; Pawluczyk S
    Am J Psychiatry; 1993 Feb; 150(2):321-3. PubMed ID: 8422085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Choline in Alzheimer's disease.
    Renvoize EB; Jerram T
    N Engl J Med; 1979 Aug; 301(6):330. PubMed ID: 377082
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.